Does RITUXIMAB Cause Intensive care unit acquired weakness? 36 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Intensive care unit acquired weakness have been filed in association with RITUXIMAB (Rituxan). This represents 0.0% of all adverse event reports for RITUXIMAB.
36
Reports of Intensive care unit acquired weakness with RITUXIMAB
0.0%
of all RITUXIMAB reports
1
Deaths
36
Hospitalizations
How Dangerous Is Intensive care unit acquired weakness From RITUXIMAB?
Of the 36 reports, 1 (2.8%) resulted in death, 36 (100.0%) required hospitalization, and 1 (2.8%) were considered life-threatening.
Is Intensive care unit acquired weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Intensive care unit acquired weakness?
METHYLPREDNISOLONE (57)
PROPOFOL (55)
MIDAZOLAM (49)
PREDNISOLONE (47)
PREDNISONE (45)
MYCOPHENOLATE MOFETIL (42)
THIOPENTAL (41)
FENTANYL (40)
LEVETIRACETAM (40)
VANCOMYCIN (37)
Which RITUXIMAB Alternatives Have Lower Intensive care unit acquired weakness Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE